MORRISVILLE,Teamm Pharmaceuticals has signed a contract to market and sell drugs from Arius Pharmaceuticals for the treatment of nausea and vomiting.

Financial terms were not disclosed.

The market for anti-nausea drugs in 2003 was $1.7 billion, according to Arius.

Arius said the deal would enable it to focus on a drug pipeline while Teamm, which is part of Accentia Biopharmaceuticals, provided sales and marketing services.